We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$13.3B
AUM Growth
+$802M
Cap. Flow
-$35.2M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.63%
Holding
2,246
New
164
Increased
893
Reduced
982
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 10.11%
3 Healthcare 10%
4 Consumer Discretionary 8.02%
5 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALV icon
1026
Autoliv
ALV
$9.02B
$2.1M 0.02%
24,890
+15,228
+158% +$1.25M
NOV icon
1027
NOV
NOV
$6.95B
$2.1M 0.02%
83,707
-21,541
-20% -$485K
SMM
1028
DELISTED
Salient Midstream & MLP Fund
SMM
$2.1M 0.02%
269,166
+32,668
+14% +$241K
NUV icon
1029
Nuveen Municipal Value Fund
NUV
$1.9B
$2.1M 0.02%
195,867
+79,950
+69% +$840K
CMP icon
1030
Compass Minerals
CMP
$1.26B
$2.07M 0.02%
33,901
-16,325
-33% -$926K
DFS
1031
DELISTED
Discover Financial Services
DFS
$2.06M 0.02%
24,308
+996
+4% +$82.2K
BBDC icon
1032
Barings BDC
BBDC
$882M
$2.06M 0.02%
200,451
+15,442
+8% +$158K
THG icon
1033
Hanover Insurance
THG
$7.98B
$2.06M 0.02%
15,077
+3,450
+30% +$464K
EVR icon
1034
Evercore
EVR
$12.3B
$2.05M 0.02%
27,468
-2,327
-8% -$177K
MOH icon
1035
Molina Healthcare
MOH
$10.2B
$2.05M 0.02%
15,109
-49,105
-76% -$6.19M
MTDR icon
1036
Matador Resources
MTDR
$5.84B
$2.05M 0.02%
113,899
+98,614
+645% +$1.47M
MPWR icon
1037
Monolithic Power Systems
MPWR
$66.1B
$2.04M 0.02%
11,457
+3,217
+39% +$514K
ROP icon
1038
Roper Technologies
ROP
$39B
$2.04M 0.02%
5,756
-189
-3% -$65.3K
BFH icon
1039
Bread Financial
BFH
$4.54B
$2.03M 0.02%
22,698
-2,618
-10% -$231K
MASI
1040
DELISTED
Masimo
MASI
$2.02M 0.02%
12,814
+2,832
+28% +$426K
OR icon
1041
OR Royalties Inc
OR
$6.04B
$2.02M 0.02%
207,670
+72,930
+54% +$666K
PNI
1042
PIMCO New York Municipal Income Fund II
PNI
$76.7M
$2.01M 0.02%
166,813
+45,542
+38% +$543K
PTLA
1043
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.01M 0.02%
84,082
+18,170
+28% +$501K
EG icon
1044
Everest Group
EG
$14.3B
$2M 0.02%
7,225
-2,613
-27% -$689K
EFF
1045
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
$2M 0.02%
124,935
+50,754
+68% +$791K
CIG icon
1046
CEMIG Preferred Shares
CIG
$6.12B
$1.96M 0.01%
1,125,956
-80,228
-7% -$131K
UFS
1047
DELISTED
DOMTAR CORPORATION (New)
UFS
$1.95M 0.01%
50,907
+5,584
+12% +$207K
MDC
1048
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.94M 0.01%
54,987
-16,562
-23% -$623K
ITUB icon
1049
Itaú Unibanco
ITUB
$90.5B
$1.94M 0.01%
291,211
+66,188
+29% +$415K
ASX icon
1050
ASE Group
ASX
$80.9B
$1.93M 0.01%
347,839
+11,630
+3% +$59.7K

Similar funds

Guggenheim Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Guggenheim Capital held 2,246 positions worth $13.3B, up 6.4% from $12.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital's Q4 2019 filing shows 164 new, 893 increased, 982 reduced and 190 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $90.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q4 2019 buy was iShares Core S&P 500 ETF: 296,002 shares worth $95.7M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q4 2019, an estimated $251M increase.
  • Guggenheim Capital's biggest Q4 2019 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $90.9M.
  • Guggenheim Capital fully exited Celgene Corp in Q4 2019, selling an estimated $33.4M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $13.3B portfolio in Q4 2019.
  • Guggenheim Capital opened 164 new positions and closed 190 in Q4 2019.
  • Guggenheim Capital's portfolio value rose 6.4% quarter-over-quarter to $13.3B.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.